168098-94-0 Usage
Explanation
This is the chemical name of the compound, which is also known as Mefloquine.
Explanation
Mefloquine has properties that help prevent and treat malaria, a disease caused by Plasmodium parasites.
Explanation
Mefloquine's chemical structure consists of a 2-amino-4-alkylamino-6-piperazine core, which is similar to the structure of quinine, another antimalarial drug.
Explanation
Mefloquine works by disrupting the life cycle of the Plasmodium parasites, preventing them from multiplying and causing further harm to the host.
Explanation
Mefloquine is available in tablet form, making it easy to administer and take as a medication.
Explanation
Some individuals may experience side effects from taking Mefloquine, which can include gastrointestinal issues, dizziness, and psychiatric symptoms.
Explanation
Due to the potential for psychiatric side effects, Mefloquine is not advised for individuals with a history of mental health issues, as it may exacerbate their condition.
Category
Antimalarial chemical compound
Structural relation
2-amino-4-alkylamino-6-piperazine, related to quinine
Mechanism of action
Interferes with growth and reproduction of malaria parasites in red blood cells
Form
Tablet
Usage
Prophylactic drug for travelers to malaria-endemic areas
Side effects
Nausea, dizziness, psychiatric symptoms
Contraindication
Not recommended for people with a history of psychiatric disorders
Check Digit Verification of cas no
The CAS Registry Mumber 168098-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,0,9 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 168098-94:
(8*1)+(7*6)+(6*8)+(5*0)+(4*9)+(3*8)+(2*9)+(1*4)=180
180 % 10 = 0
So 168098-94-0 is a valid CAS Registry Number.
168098-94-0Relevant articles and documents
A convenient procedure for the synthesis of O6-benzylguanine derivatives by phase transfer catalysis
Liu, Xuan,Zheng, Qi-Huang,Hutchins, Gary D.,Fei, Xiangshu,Erickson, Leonard C.,Miller, Kathy D.,Mock, Bruce H.,Glick-Wilson, Barbara E.,Winkle, Wendy L.,Stone, K. Lee,Carlson, Kathy A.
, p. 941 - 952 (2007/10/03)
A convenient procedure by phase transfer catalysis has been developed for the synthesis of O6-BG (1) and its derivatives hydroxymethyl-BG (2a-c), halo-BG (3a-c, 4a-c, 5a-c, 6a-c), methoxy-BG (7), and methyl-BG (8). Compounds 2b, 2c, 4b, 4c, 5b, 5c, 6a, and 6c are new compounds.
